Merck CEO: Generic Singulair, uncertain economy to make 2012-13 difficult, but he’s optimistic - Washington Post

TRENTON, N.J. — Merck & Co. CEO Kenneth Frazier told company shareholders on Tuesday that 2012 and 2013 will be difficult years, but he’s confident the company can weather them. Speaking at the company’s annual meeting, Frazier noted the drugmaker ...

Asthma: possible association between Singulair and behavior/mood changes, suicidality and suicide - Xagena Medical News

The FDA ( Food and Drug Adminsitration ) is investigating a possible association between the use of Singulair ( Montelukast ) and behavior/mood changes, suicidality ( suicidal thinking and behavior ) and suicide. Singulair is a medicine in the drug class ...

Merck and Mylan Look to Benefit From Plan to Speed up FDA Reviews - msnbc.com

Worldwide sales of SINGULAIR, a once-a-day oral medicine for the chronic treatment of asthma and the relief of symptoms of allergic rhinitis, grew 1 percent from the first quarter of 2011 to $1.3 billion. The U.S. patent for SINGULAIR will expire in Aug ...

4 Big Pharma Stocks To Nab In A Pullback - Seekingalpha.com

Merck (MRK) beat consensus earnings estimates in the most recent quarter by one cent and continues to enjoy a modest but steady rise in share value, even though its apex breadwinner, Singulair, is winding its way to a U.S. patent expiration on August 3rd ...

Merck: Manufacturing Portfolio Health With Dividend Income - Seekingalpha.com

Its track record in acquisitions is also poor. The major concern for Merck I see going forward is the significant loss in revenue caused by their blockbuster Singulair going off patent in August, especially since there seems to be limited options on the ...

Generic Plavix® to Arrive at All Walmart and Sam's Club Pharmacies on May 19 - Marketwatch

BENTONVILLE, Ark., May 16, 2012 /PRNewswire via COMTEX/ -- Walmart (NYSE:WMT) announced today that it will be among the first retailers to offer Clopidogrel, the generic version of Plavix®. Clopidogrel will be available at all Walmart and Sam's ...

Major Pharmaceuticals Prepare Themselves for Patent Expirations in 2012 - Yahoo Finance

Merck's worldwide sales of SINGULAIR (montelukast sodium), a once-a-day oral medicine for the chronic treatment of asthma and the relief of symptoms of allergic rhinitis, grew 1 percent from the first quarter of 2011 to $1.3 billion. The U.S ...

Allergy relief all in your head - Columbian

As for medications, Dr. Lawrence says there are three basic groups: antihistamines, nasal cortisone sprays, and leukotriene blockers (the Singulair group). “All of them have shown to be effective,” said Dr. Lawrence. “Most people do well with antihistamines.

DUI Charges - Beaver County Times

Shillingburg told township police she suffers from COPD and asthma and took Singulair and Claritin and had a breathing treatment that morning. Police said she also took Percocet as directed around 8:30 a.m. Upon a vehicle search, police found four bottles ...

The healthy and wise ways to battle asthma - PRLog (free press release)

Our website is the one stop information centre regarding the causes and cures of asthma. The brand name for Montelukast is Singulair. It belongs to the Leukotriene receptor antagonist or LTRA group of drugs. Drugs belonging to this class block the actions ...